Parkside Financial Bank & Trust Catalyst Pharmaceuticals, Inc. Transaction History
Parkside Financial Bank & Trust
- $742 Million
- Q4 2024
A detailed history of Parkside Financial Bank & Trust transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 2,655 shares of CPRX stock, worth $56,418. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,655
Previous 2,655
-0.0%
Holding current value
$56,418
Previous $52,000
5.77%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding CPRX
# of Institutions
345Shares Held
98.4MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$397 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$179 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$123 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$66.6 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$64 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.18B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...